Door to Balloon Time in St-Segment Elevation Myocardial Infarction (STEMI): A Prospective Study
S. S. Bansal, Siddhant Bansal, Chetan Swaroop
Cardiology and Angiology: An International Journal · pp. 10–16 · Published 9 Apr 2022
10.9734/ca/2022/v11i330196Abstract
Background: The most acute manifestation of coronary artery disease is ST-segment elevation myocardial infarction (STEMI) and is associated with mortality and morbidity. In the majority of cases, complete thrombotic occlusion develops from an atherosclerotic plaque in an epicardial coronary vessel is the cause of STEMI. Early diagnosis and immediate reperfusion reduce the risk of post-STEMI complications and heart failure and thereby are the most effective ways to limit myocardial ischemia and infarct size. If primary percutaneous coronary intervention (PCI) cannot be performed within 120 minutes of STEMI diagnosis, fibrinolysis therapy should be administered to dissolve the occluding thrombus and PCI has become the preferred reperfusion strategy in patients with STEMI. Methods: From the emergency section of the hospital in the month of October 2021, 7 adult patients were identified with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary. We used the framework of regression discontinuity to test for discontinuity at 90 minutes among the included cases. The Door - Balloon as 90 minutes minus the time between hospital arrival and catheterization laboratory arrival -defined as a novel variable. To assess the relationship between remaining Door - Balloon time and access site we have estimated multivariable logistic regression models. Results: The results of primary PTCA in the month of October 2021 were performed in less than 90 minutes without any mortality in 7 patients. Conclusions: Our Data on mortality and morbidity benefits of primary angioplasty shows a 100% decrease in mortality of patients undergoing primary PTCA within 90 minutes as compared to international data which shows a 40% decrease.
Cited by 1
ABU SAFANA BISWAS, GANAVI BETHANAGERE RAMESHA, KAMSAGARA LINGANNA KRISHNA · International Journal of Applied Pharmaceutics · 2025
Related research
- Oxidative Stress Biomarkers (Malondialdehyde, Superoxide Dismutase, and Catalase) as Predictors of Cardiovascular Disease Risk: A Review — shares topic coverage
- - 251 A/T Single Nucleotide Polymorphism of Interleukin 8 and Susceptibility to Acute Myocardial Infarction — shares topic coverage
- The Relation of Vitamin D Status and Presence of Acute Coronary Syndrome in Patients — shares topic coverage
- Arginase Activity as a Useful Cardiac Marker for Differential Diagnosis of UA and MI: A Pilot Study — shares topic coverage
- Angiotensin-I-Converting Enzyme (ACE) Insertion/Deletion Polymorphism in Egyptian Patients with Coronary Artery Disease — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.